Medicine and Dentistry
Diabetes
100%
Patient with Type 2 Diabetes
92%
COVID-19
66%
Maturity Onset Diabetes of the Young
49%
Glycemic Control
46%
Infection
38%
Thromboprophylaxis
33%
Patient Satisfaction
33%
Diseases
33%
Consultation
33%
Predictive Marker
33%
Telemedicine
33%
Parathyroid Hormone
33%
Passive Immunization
33%
Calcifediol
33%
Epileptic Seizure
33%
Nasal Cannula
33%
Biological Therapy
33%
Metabolic Dysfunction-Associated Steatotic Liver Disease
33%
Intubation
33%
Survival Analysis
33%
Postcovid Syndrome
33%
Night Eating Syndrome
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Anorexia Nervosa
33%
Bulimia
33%
Metabolic Regulation
33%
Cardiology
33%
Body Mass Index
28%
Fractional Flow Reserve
27%
Exome Sequencing
22%
Combination Therapy
16%
Mood Disorder
16%
Dyslipidemia
16%
Umbilical Cord
13%
Hemoglobin A1c
13%
Diabetic Neuropathy
13%
Blood Pressure
13%
Primary Health Care
12%
Central Nervous System
11%
Hypogammaglobulinemia
11%
Hypothyroidism
11%
Dysmorphic Feature
11%
Skeletal System
11%
Care (Medicine)
11%
Pathophysiology
11%
Quality of Life
11%
Promoter Region
9%
Pressure Control
9%
Low Density Lipoprotein Cholesterol
9%
Nursing and Health Professions
Hemoglobin A1c
42%
Patient with Type 2 Diabetes
40%
Infection
38%
Colecalciferol
33%
Calcifediol
33%
Supplementation
33%
Spike
33%
BNT162b2 vaccine
33%
Immunoglobulin G Antibody
33%
Diagnostic Accuracy
33%
Coronary Angiography
33%
Hypothyroidism
33%
Fluoroscopy
33%
Nonalcoholic Fatty Liver
33%
Nasal Cannula
33%
Survival Analysis
33%
Intubation
33%
Liver Disease
33%
Psoriasis
33%
Biological Therapy
33%
Severe Acute Respiratory Syndrome
33%
Cardiovascular Risk
33%
Optical Coherence Tomography
27%
Intravascular Ultrasound
27%
Non Insulin Dependent Diabetes Mellitus
25%
Body Mass
24%
Echocardiography
24%
Combination Therapy
22%
Dyslipidemia
20%
Diabetes Mellitus
16%
Care (Medicine)
16%
Longitudinal Analysis
16%
Glucose Level
16%
Area under the Curve
14%
Proportional Hazards Model
11%
Skin Temperature
11%
Low Density Lipoprotein Cholesterol
9%
Metabolic Parameters
9%
Pressure Control
9%
Albuminuria
9%
Ophthalmoscopy
8%
Electronic Medical Record
6%
Oxygen Therapy
6%
Respiratory Failure
6%
Survival Rate
6%
Medical History
6%
Decision Trees
6%
Levothyroxine
5%
Urban Population
5%
Insulin Treatment
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
46%
Immunoglobulin G
38%
Nonalcoholic Fatty Liver
33%
Adverse Outcome
33%
Adverse Event
33%
Hypocalcaemia
33%
Secondary Hyperparathyroidism
33%
Parathyroid Hormone
33%
Tertiary Hyperparathyroidism
33%
Heart Ventricle Hypertrophy
33%
N (4 Methoxyphenylacetyl)dehydroalanine
33%
Infection
33%
Hypoglycemia
33%
Cholecalciferol
33%
Infection Rate
33%
Combination Vaccine
33%
Heart Left Ventricle Hypertrophy
33%
Intubation
33%
Acylcarnitine
33%
Syndrome
33%
Comorbidity
33%
Prevalence
33%
Cardiovascular Risk
33%
Dyslipidemia
26%
Medical History
23%
Hyperphosphatemia
16%
Hypercalcaemia
16%
Diabetic Neuropathy
16%
Cyclorphan
16%
Diabetic Retinopathy
16%
Pandemic
16%
Mortality Rate
16%
Mood Disorder
13%
Additive Interaction
13%
Glycosylated Hemoglobin
11%
Antidiabetic Agent
11%
Retinopathy
6%
Neuropathy
6%
Retrospective Study
6%
Survival Rate
6%
Respiratory Failure
6%
mRNA Vaccine
6%
Biological Product
5%
Disease Predisposition
5%
